DAIC

NOVEMBER 8, 2024

Major adverse limb events (target vessel revascularization, major target limb amputation, and target lesion thrombosis) through 12 months did not differ between groups. in 11 RCTs) were also similar or better than meta-analysis rates for balloon angioplasty or DCB, with variations based on study design and artery level.3-6

Stents 52

Stents Stent Angioplasty Peripheral Arterial Disease 52

DAIC

JANUARY 23, 2024

12,16 In 2017, CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) provided proof-of-principle that inflammation inhibition in the absence of lipid lowering can significantly reduce cardiovascular event rates and helped to define the interleukin-1 (IL-1) to IL-6 to CRP pathway as a central target in CV disease.16

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

Frontiers in Cardiovascular Medicine

NOVEMBER 25, 2024

Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.

Cardiovascular Disease 59

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Thrombosis 59

AMS Cardiology

MARCH 20, 2025

Common Vascular Conditions We Treat Some vascular diseases affect your arteries while others occur in your veins. Atherosclerosis & Arterial Diseases Peripheral Artery Disease (PAD) : A blockage in your legs. Carotid Artery Disease : A blockage or narrowing in the arteries supplying your brain.

Vascular Care 52

Vascular Care Blood Clot Aneurysm Aortic 52